The Food and Drug Administration (FDA) will be holding a public meeting entitled ‘‘Oncology Center of Excellence (OCE): Listening Session,’’ on Thursday, March 15, 2018, from 9 AM to 12 PM. The listening session is an opportunity for stakeholders such as the advocacy community and oncology professional societies to provide recommendations to the Agency regarding the OCE. Specifically, we are soliciting comments regarding what stakeholders desire of the OCE in terms of structure, function, regulatory purview, and activity. Register for the meeting here or read more in the Federal Register Notice.
The European Medicines Agency (EMA) has announced that it is planning its Second international Awareness Session for International Regulators, Academia and Non-governmental Organizations. The session will be held at the EMA in London, on March 8-9, 2018.
Places are limited so early expression of interest is recommended and should be sent by February 16, 2018 to EMA at the following email address: EMAinternational@ema.europa.eu.
The ISPE Board of Directors has created a special elected category of membership for its outstanding leadership. Fellowship Status is awarded upon election as Fellow by the Board on the recommendation of a committee of peers (the Fellowship & Awards Committee). Members must meet or exceed several criteria including at least 5 consecutive years of non-student membership. For more information click here.
ISPE Asian Scientific meeting
Deadline: June 15, 2018
ISPE members in Asia that would like to host an ISPE Asian Scientific Meeting in their country in 2020 or 2021 are invited to submit a proposal by June 15, 2018. Click here for the guidelines to become a Local Host.
Submit an abstract for an oral/poster presentation or a symposium/workshop for presentation at the 34th ICPE/Prague. Click here to submit an abstract. The deadline is February 14, 2018.
The 2018 ICPE Scholarship application is available. Click here to view.